|Podcasts|July 21, 2022
Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 2
In part 2 of this 2-part podcast, a panel of experts provide a review of the treatment landscape of systemic sclerosis interstitial lung disease (ILD) and discuss unmet needs and emerging therapies in ILD.
Advertisement
Today we are bringing you part 2 of a 2-part sponsored podcast series discussing treatment goals in insterstitial lung disease (ILD). The discussion was moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute.
The conversation for today’s podcast includes an in-depth review of treatment landscape of systemic sclerosis ILD as well as a discussion on unmet needs and emerging therapies in ILD.
Listen above or through one of these podcast services:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Judge Denies Preliminary Injunction in Medicaid Work Requirements Case
2
AHRQ Grant Freeze Halts Patient Safety Research Nationwide
3
Contributor: Artificial Intelligence Grows Across Health Care, Led by Administrative Processes
4
FDA Advisory Panel Votes Against Approval of Deramiocel for DMD
5